Notification card to alert for methicillin-resistant Staphylococcus aureus is stigmatizing from the patient's point

Eva Skyman1, Ingegerd Bergbom, Berit Lindahl

  • 1From the 1 Infection Control Unit, Institution of Biomedicine, Department of Infectious Diseases, University of Gothenburg.

Abstract

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) notification cards help patients inform healthcare systems but can lead to stigmatizing experiences. Education for healthcare professionals on managing multidrug-resistant bacteria (MRB) is crucial.

Area of Science:

  • Infectious Diseases
  • Patient Experience
  • Healthcare Management

Background:

  • Guidelines emphasize alerting healthcare systems to patients carrying multidrug-resistant bacteria (MRB).
  • Notification cards are recommended when electronic alert systems are unavailable but are rarely evaluated.
  • This study evaluated patient experiences with methicillin-resistant Staphylococcus aureus (MRSA) notification cards.

Purpose of the Study:

  • To assess patient experiences with MRSA notification cards.
  • To identify challenges and benefits associated with using these cards for patient notification.

Main Methods:

  • Two cohorts of MRSA carriers (1999-2003 and 2008-2010) completed questionnaires.
  • Response rates were high, with a significant portion providing qualitative comments.
  • Qualitative analysis was used to interpret patient feedback.

Main Results:

  • Patients reported high card usage and a sense of responsibility to prevent infection spread.
  • However, patients experienced fear, disrespect, and unprofessional behavior when presenting the card.
  • These stigmatizing experiences increased in the later cohort (2011).

Conclusions:

  • MRSA notification cards can stigmatize patients, questioning their utility.
  • Development of alternative alert methods is needed.
  • Educating healthcare professionals about MRB management is urgently required.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
143
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.0K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.7K